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ABSTRACT
Objective: We aimed to know the expectations of a pediatric intensive care unit staff for the activities
to be undertaken by the clinical pharmacist, in order to plan her work along with the multidisciplinary
team.
Study design: A cross-sectional study, involving the multidisciplinary team of the pediatric intensive
care unit of a tertiary-care university hospital.
Method: A self-completion questionnaire containing questions regarding expectations of the pediatric
intensive care unit staff for the role of the clinical pharmacist in the multidisciplinary team was applied
to the team members, using a Likert-type scale response.
Results: The nursing assistants/technicians and physiotherapists showed higher expectation for issues
related to administration of medications; for nurses, the expectation for the clinical pharmacist perform-
ance focused on issues related to prescription drugs, such as evaluation of antibiotic therapy, while
physicians considered most important information on drug therapy, as notification of allergies related to
drugs, information on period of validity of medicines and evaluation of drug administration by gastric or
enteral tubes.
Conclusions: Team expectations varied according to the needs and routine of each professional cat-
egory. The results of this study have contributed to implementation of the clinical pharmacy service in a
Brazilian pediatric intensive care unit.
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Introduction
Iatrogenic injuries caused by medication er-
rors are common among hospitalized patients.1,2
Some studies have evaluated the impact of inter-
ventions aimed at reducing these errors, including
computerization of prescription and dispensation of
drugs.3,4 However, teamwork as a strategy to cope
with the intense process of specialization in health
care has been shown as an alternative that may
contribute to patient safety and efficacy of pharma-
cotherapy.2,5
Physicians are responsible for prescription,
pharmacists for dispensing medications and nurses
for administering them to the patient, and for a long
time, these professionals have provided their as-
sistance separately and not as a team. Currently,
clinical pharmacists work in collaboration with other
health professionals, ensuring greater safety for the
patient through exchange of information and knowl-
edge.6 In this context, the clinical pharmacist plays
a key role in multidisciplinary teams of intensive
care units, as patients’ clinical characteristics, com-
plexity of medications and large daily variation of
prescriptions demand a comprehensive pharmaco-
therapeutic assessment.7-10
Several causes of medication errors resulting
in harm to children have been reported in the lit-
erature, including individualized drug dosage based
on weight, which can result in miscalculations, adult
formulations for pediatric use, health services de-
signed to better accommodate the adult popula-
tion, children’s inability to communicate effectively
with health professionals about adverse events that
might be occurring and failure to physiologically
tolerate the consequences of medication errors.2
According to Kaushal et al., the potential risk
for medication errors in pediatric patients is about
three times higher than in adults.11 Indeed, there is
evidence that clinical pharmacist interventions have
a significant impact on reducing medication errors
in pediatric hospitals.12 However, the inclusion of
clinical pharmacists in the multidisciplinary team still
faces difficulties in Brazil, since this work requires
vast amounts of commitment in terms of time and
effort, which precludes the recruitment of health
professionals to perform this task. In addition, there
is a shortage of specific training courses for clinical
pharmacists in Brazil.
In our institution, a clinical pharmacist has
been assigned to work in the pediatric intensive care
unit since July 2014. Thus, this study aimed to know
RESUMO
Objetivo: O objetivo do estudo foi conhecer as expectativas da equipe da unidade de terapia intensiva
pediátrica quanto às atividades a serem realizadas pelo farmacêutico clínico a fim de planejar seu
trabalho junto com a equipe multidisciplinar.
Desenho do estudo: Estudo transversal, envolvendo a equipe multidisciplinar da unidade de terapia
intensiva pediátrica de um hospital universitário terciário.
Método: Um questionário autopreenchível contendo perguntas sobre as expectativas da equipe da
unidade de terapia intensiva pediátrica em relação ao papel do farmacêutico clínico na equipe multidis-
ciplinar foi aplicado aos membros da equipe, utilizando a escala de resposta do tipo Likert.
Resultados: Os auxiliares/ técnicos de enfermagem e fisioterapeutas mostraram maior expectativa em
relação a questões relacionadas com a administração de medicamentos; para enfermeiros, a expectati-
va sobre o desempenho do farmacêutico clínico focou-se em questões relacionadas à prescrição de
medicações, como a avaliação da antibioticoterapia, enquanto os médicos consideraram mais importan-
tes informações sobre a terapia medicamentosa, como a notificação de alergias relacionadas às drogas,
informações sobre o aprazamento de medicamentos e avaliação da administração de drogas por sonda
gástrica ou enteral.
Conclusões: As expectativas da equipe variaram de acordo com as necessidades e a rotina de cada
categoria profissional. Os resultados deste estudo têm contribuído para a implantação do serviço de
farmácia clínica em uma unidade de terapia intensiva pediátrica brasileira.
Palavras-chave: Serviço de Farmácia Hospitalar. Equipe de Assistência ao Paciente. Segurança do
Paciente. Pediatria.
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the expectations of the pediatric intensive care unit
staff for the activities to be undertaken by the clini-
cal pharmacist, in order to plan her work along with
the multidisciplinary team.
Methods
Study design
This was a cross-sectional study, which con-
sisted of the application of a self-completion ques-
tionnaire to staff members of the pediatric inten-
sive care unit of Hospital das Clínicas of Ribeirão
Preto Medical School, University of São Paulo, Bra-
zil. The study was approved by the Institutional
Research Ethics Board (#596/2014) and written
informed consent was obtained from the partici-
pants.
The pediatric intensive care unit of Hospital
das Clínicas of Ribeirão Preto Medical School had at
the time of the study 77 staff members. The inclu-
sion criteria were to work at the pediatric intensive
care unit for at least six months and agreement to
participate. Team members working in the unit for
less than six months or those who refused to par-
ticipate were excluded. Therefore, the survey was
conducted with a convenience sample of 50 profes-
sionals who agreed to participate, including 24 nurs-
ing assistants/ technicians, 13 nurses, eight doc-
tors, three physiotherapists, one nutritional thera-
pist and one administrative officer.
Data collection
The instrument used for data collection was
a self-completion questionnaire developed by the
authors, containing questions regarding expecta-
tions of the pediatric intensive care unit staff mem-
bers for the role of the clinical pharmacist in the
multidisciplinary team. The questionnaire was ap-
plied to the professionals, using a Likert-type scale
response featuring three points: 1 = unimportant
or irrelevant; 2 = important and 3 = very impor-
tant or essential, allowing participants to answer
the questions according to varying degrees of im-
portance of each item used to describe the task.
The self-completion questionnaire was constructed
based on a literature review regarding activities
developed by the clinical pharmacist, and included
15 items13 (Table 1). A pilot study was conducted
with three professionals (a physician, a nurse and a
nursing assistant) who were eligible for the study.
The objective of the pilot study was to verify the
understanding of the questions by the team mem-
bers, intelligibility and clarity of the research ques-
tions as well as possible difficulties. No change was
made in the questionnaire after the pilot study.
Table 1: Activities developed by the clinical pharmacist
1. Daily assessment of prescriptions
2. Evaluation of antibiotic therapy
3. Recommendation for dose adjustment according to kidney and liver function
4. Recommendation for replacement of non-standard prescription by standardized medication
5. Recommendation for replacement of route of administration, when necessary
6. Providing information for the prescriber on incompatibility between the drug and the diluent, drug stability and
infusion time of drugs
7. Notification of known patient drug allergies
8. Monitoring of prescriptions (replacements, omissions and possible issues)
9. Checking for use of opioids and other psychotropic medications and their side effects
10. Checking for drug interactions that may cause damage or therapeutic failure
11. Drug Reconciliation: reconciling prescribed medications with those already in use by the patient
12. Provision of pharmaceutical care at hospital discharge
13. Providing information on period of validity of medicines
14. Evaluation of drug administration by gastric or enteral route, including location of the tube and drug absorption,
and whether it is possible to triturate the drug
15. Providing information about drugs that may cause phlebitis
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Data analysis
Data were analyzed by correspondence analy-
sis, which consists of a multivariate statistical
method that allows measuring and visualizing the
degree of association between a set of categories
of qualitative variables. When applied to the analy-
sis of the responses of the study questionnaire, it
indicates the degree of association of different items
on a Cartesian graph called correspondence map.
In correspondence analysis, the total variation of
the data is called inertia, which is decomposed in
each axis (or dimension) of the graph. Thus, the
inertia associated with each dimension of the graph
tells us what proportion of the total variation is ex-
plained by that axis.14
Results
Figure 1 shows the correspondence map gen-
erated from correspondence analysis of the responses
to the 15 questions. The coordinates of the ques-
tionnaire responses and professional categories are
in dimensions 1 and 2, which account for 71% of
total inertia, i.e., a large part of the data variation is
explained by these axes. Professional categories are
represented in the correspondence map by abbre-
viations (NA, nursing assistants/ technicians; PHY
physiotherapist; RN, nurse; MD, physician; OP, other
professionals), where the numbers relate to the ques-
tion of the questionnaire and the letter accompany-
ing them refers to the degree of importance (a, of
little importance or irrelevant; b, important; c, very
important or essential). The correspondence of a
professional category with the questionnaire re-
sponses is represented by the distance on the graph.
The items shown in the central area of the graph are
associated to a greater degree.
As shown in Figure 1, nursing assistants/ tech-
nicians and physiotherapists had a higher expecta-
tion for issues related to drug administration as rec-
ommendation for replacement of route of adminis-
tration, when necessary (5b and 5c) and evaluation
of drug administration by gastric or enteral tubes
(14c). In addition, they considered drug reconcilia-
Figure 1: Correspondence map generated from correspondence analysis of questionnaire responses.
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tion (11c), notification of drug allergies (7c), moni-
toring of prescriptions (8c) and recommendation for
replacement of non-standard prescription by stan-
dardized medication (4c) as very important or es-
sential. Also, they considered the practice of phar-
maceutical care at hospital discharge as very im-
portant (12c).
For nurses, the expectations for the clinical
pharmacist performance focused on issues related
to prescription drugs such as evaluation of antibi-
otic therapy (2c and 2b), recommendation for dose
adjustment according to kidney and liver function
(3c), recommendation for replacement of non-stan-
dard prescription by standardized medication (4b)
and information about drug interactions that may
cause damage or therapeutic failure (10c). They also
considered very important or important information
on incompatibility between the drug and the diluent,
drug stability and infusion time of drugs (6c), daily
assessment of prescriptions (1c), drug reconcilia-
tion (11b) and provision of pharmaceutical care at
hospital discharge (12b).
On the other hand, physicians considered
most important notification of drug allergies (7b),
information on period of validity of medicines (13b)
and evaluation of drug administration by gastric or
enteral tubes (14b). Other professional categories
expected the clinical pharmacist to check for the
use of opioids and other psychotropic drugs (9b)
and the presence of drug interactions that may cause
damage or therapeutic failure (10b).
Discussion
Successful implementation of clinical phar-
macy practice requires that clinical pharmacists work
in collaboration with physicians, nurses and other
members of the health care team. Therefore, it is
important to know the expectations of the staff for
the clinical pharmacists’ roles to support an effec-
tive implementation of the clinical pharmacy ser-
vice. In our study, the nursing staff judged most
relevant issues related to drug administration while
physicians considered information on drug therapy
as more important. These differences in health care
team expectations for the clinical pharmacist per-
formance may be attributed to the specificities of
function and routine of each professional category.
The pediatric intensive care unit staff of our
institution was receptive to the clinical pharmacist’s
practice as most tasks to be undertaken by the clini-
cal pharmacist were considered important or very
important. Accordingly, the majority of physicians
in Ethiopia were receptive to the clinical pharma-
cists’ roles as drug therapy experts and patient edu-
cators on appropriate use of medications.15 In con-
trast, in Jordan, only 16.3% of physicians were com-
fortable with pharmacists suggesting the use of pre-
scription medications to physicians.16 This discom-
fort has been attributed to lack of interaction among
the health care professionals, as more than a third
of physicians stated they rarely interacted with phar-
macists. However, clinical pharmacists must work
closely with physicians and other members of the
health care team  in order to optimize drug therapy
and improve patient’s outcome.17,18
In North America, clinical pharmacy was char-
acterized in the 60’s, aimed at promoting safe and
rational use of medications and cost savings. In
Brazil, the area of clinical pharmacy has recently
expanded. In February 2010, the Board Resolution
from the National Health Surveillance Agency
(ANVISA) included pharmaceutical assistance at
bedside as part of the multidisciplinary care within
the minimum requirements for operation of inten-
sive care units (Ministério da Saúde, Agência
Nacional de Vigilância Sanitária, Resolução-RDC nº
7, de 24 de fevereiro de 2010). In addition, since
2014, a residency program in Clinical Pharmacy and
Pharmaceutical Care at the Faculty of Pharmaceuti-
cal Sciences of the University of São Paulo has been
established. Moreover, in a large tertiary-care hos-
pital in São Paulo, a clinical pharmacy service showed
a positive impact in rational use of medications and
patient safety.19 Hence, urgent action and invest-
ments are needed to facilitate implementation of
clinical pharmacy services in Brazil.
The main limitation of this study includes the
lack of a comparison group because the research
was designed specifically for the pediatric intensive
care unit. However, the study is innovative as it
showed the expectations of the professional team
that have contributed to direct the activities of the
clinical pharmacist and to the implementation of the
clinical pharmacy service in a pediatric intensive care
unit of a tertiary-care university hospital.
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Conclusion
The expectations of the pediatric intensive
care unit multidisciplinary team for the clinical phar-
macist performance varied according to the needs
and practice of each professional category. The re-
sults of this study have contributed to implementa-
tion of the clinical pharmacy service in a Brazilian
pediatric intensive care unit.
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